BACKGROUND: Genetic and environmental factors jointly influence cancer risk. The NIH has made the study of gene-environment (GxE) interactions a research priority since the year 2000. METHODS: To assess the current status of GxE research in cancer, we analyzed the extramural grant portfolio of the National Cancer Institute (NCI) from Fiscal Years 2007 to 2009. Publications attributed to selected grants were also evaluated. RESULTS: From the 1,106 research grants identified in our portfolio analysis, a random sample of 450 grants (40%) was selected for data abstraction; of these, 147 (33%) were considered relevant. The most common cancer type was breast (20%, n = 29), followed by lymphoproliferative (10%, n = 14), colorectal (9%, n = 13), melanoma/other skin (9%, n = 13), and lung/upper aerodigestive tract (8%, n = 12) cancers. The majority of grants were studies of candidate genes (68%, n = 100) compared with genome-wide association studies (GWAS) (8%, n = 12). Approximately one-third studied environmental exposures categorized as energy balance (37%, n = 54) or drugs/treatment (29%, n = 43). From the 147 relevant grants, 108 publications classified as GxE or pharmacogenomic were identified. These publications were linked to 37 of the 147 grant applications (25%). CONCLUSION: The findings from our portfolio analysis suggest that GxE studies are concentrated in specific areas. There is room for investments in other aspects of GxE research, including, but not limited to developing alternative approaches to exposure assessment, broadening the spectrum of cancer types investigated, and conducting GxE within GWAS. IMPACT: This portfolio analysis provides a cross-sectional review of NCI support for GxE research in cancer.
BACKGROUND: Genetic and environmental factors jointly influence cancer risk. The NIH has made the study of gene-environment (GxE) interactions a research priority since the year 2000. METHODS: To assess the current status of GxE research in cancer, we analyzed the extramural grant portfolio of the National Cancer Institute (NCI) from Fiscal Years 2007 to 2009. Publications attributed to selected grants were also evaluated. RESULTS: From the 1,106 research grants identified in our portfolio analysis, a random sample of 450 grants (40%) was selected for data abstraction; of these, 147 (33%) were considered relevant. The most common cancer type was breast (20%, n = 29), followed by lymphoproliferative (10%, n = 14), colorectal (9%, n = 13), melanoma/other skin (9%, n = 13), and lung/upper aerodigestive tract (8%, n = 12) cancers. The majority of grants were studies of candidate genes (68%, n = 100) compared with genome-wide association studies (GWAS) (8%, n = 12). Approximately one-third studied environmental exposures categorized as energy balance (37%, n = 54) or drugs/treatment (29%, n = 43). From the 147 relevant grants, 108 publications classified as GxE or pharmacogenomic were identified. These publications were linked to 37 of the 147 grant applications (25%). CONCLUSION: The findings from our portfolio analysis suggest that GxE studies are concentrated in specific areas. There is room for investments in other aspects of GxE research, including, but not limited to developing alternative approaches to exposure assessment, broadening the spectrum of cancer types investigated, and conducting GxE within GWAS. IMPACT: This portfolio analysis provides a cross-sectional review of NCI support for GxE research in cancer.
Authors: Ebony B Bookman; Kimberly McAllister; Elizabeth Gillanders; Kay Wanke; David Balshaw; Joni Rutter; Jill Reedy; Daniel Shaughnessy; Tanya Agurs-Collins; Dina Paltoo; Audie Atienza; Laura Bierut; Peter Kraft; M Daniele Fallin; Frederica Perera; Eric Turkheimer; Jason Boardman; Mary L Marazita; Stephen M Rappaport; Eric Boerwinkle; Stephen J Suomi; Neil E Caporaso; Irva Hertz-Picciotto; Kristen C Jacobson; William L Lowe; Lynn R Goldman; Priya Duggal; Megan R Gunnar; Teri A Manolio; Eric D Green; Deborah H Olster; Linda S Birnbaum Journal: Genet Epidemiol Date: 2011-05 Impact factor: 2.135
Authors: Muin J Khoury; Marta Gwinn; Paula W Yoon; Nicole Dowling; Cynthia A Moore; Linda Bradley Journal: Genet Med Date: 2007-10 Impact factor: 8.822
Authors: Carolyn M Hutter; Leah E Mechanic; Nilanjan Chatterjee; Peter Kraft; Elizabeth M Gillanders Journal: Genet Epidemiol Date: 2013-10-05 Impact factor: 2.135
Authors: Ronald E Myers; Karen Ruth; Sharon L Manne; James Cocroft; Randa Sifri; Barry Ziring; Desiree Burgh; Eric Ross; David S Weinberg Journal: J Behav Med Date: 2015-03-18
Authors: David S Weinberg; Ronald E Myers; Eileen Keenan; Karen Ruth; Randa Sifri; Barry Ziring; Eric Ross; Sharon L Manne Journal: Ann Intern Med Date: 2014-10-21 Impact factor: 25.391
Authors: Naoko I Simonds; Armen A Ghazarian; Camilla B Pimentel; Sheri D Schully; Gary L Ellison; Elizabeth M Gillanders; Leah E Mechanic Journal: Genet Epidemiol Date: 2016-04-07 Impact factor: 2.135
Authors: Armen A Ghazarian; Naoko Ishibe Simonds; Gabriel Y Lai; Leah E Mechanic Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-12-15 Impact factor: 4.090